Quality indicators for type-2 diabetes care in practice guidelines: An example from six European countries

Abstract Introduction Diabetes mellitus patients need a multidisciplinary management and rigorous follow up. Quality indicators are important to assess and improve the quality of the health-care delivery. Less straightforward, however, is choosing which indicators to use for the assessment of the di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Primary care diabetes 2007-02, Vol.1 (1), p.17-23
Hauptverfasser: Wens, Johan, Dirven, Kristien, Mathieu, Chantal, Paulus, Dominique, Van Royen, Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Introduction Diabetes mellitus patients need a multidisciplinary management and rigorous follow up. Quality indicators are important to assess and improve the quality of the health-care delivery. Less straightforward, however, is choosing which indicators to use for the assessment of the disease management. Methods Review of guidelines. Process and outcome indicators were extracted out of type-2 diabetes guidelines from Belgium and its neighbouring countries. The “most evidence based” indicators were derived after applying a “best evidence” ratio. Results Thirty-four indicators were classified in five diabetes management topics: (1) control of glycaemia, (2) early detection of glycaemic complications, (3) treatment of glycaemic complications, (4) cardiovascular disease and, (5) quality of life. Target values to outcome indicators and appropriate specifications to process indicators were not assigned because direct transfer to different countries is not possible without considering contextual information such as typical preconditions of every society and health-care system. Conclusion Although not all aspects of care are described in guidelines, five ‘mini’ lists of highly valuable indicators for optimal treatment in the field of type-2 diabetes could be drawn up. The target sets for indicators’ values and specifications are a matter of ongoing concern because evidence changes over time.
ISSN:1751-9918
1878-0210
DOI:10.1016/j.pcd.2006.07.001